Advancing Neurological Therapies: Integrating Novel Compounds and Clinical Trials for Enhanced Cognitive and Neuronal Health

Abstract

This Highlight explores three innovative clinical frameworks from recent patents, each introducing unique neuropharmaceutical compounds with potential therapeutic applications in cognitive and neurological health. This paper outlines their mechanisms, therapeutic benefits, and integrated clinical trial designs to prove efficacy and safety, demonstrating how these diverse approaches converge on advancing neurological treatment paradigms. ImportantCompound Classes. Titles. Method of Administration of a Parenteral Formulation Comprising a Psychedelic Agent; Composition Comprising not Phosphorylated Tryptamine, Antioxidants, and Supplements, and Pharmaceutical Uses Thereof; and Phenoxy and Benzyloxy Substituted Psychoplastogens and Uses Thereof.